熱門資訊> 正文
Vaxart宣布2500万美元的股票购买协议
2026-04-17 21:16
- Vaxart (VXRT) said on Friday it had entered into a share purchase agreement with Lincoln Park Capital Fund to sell up to $25 million of common stock over 24 months.
- Share sales under the agreement had been structured under registration exemptions and remained subject to SEC effectiveness of a registration statement and other conditions.
- Under the agreement, Vaxart retained full control over the timing and amount of sales, with pricing tied to market levels, no warrants or participation rights, and restrictions on short selling by Lincoln Park.
- Shares -0.21%.
More on Vaxart
- Vaxart, Inc. (VXRT) Shareholder/Analyst Call Transcript
- Vaxart, Inc. (VXRT) Q4 2025 Earnings Call Transcript
- Vaxart, Inc. (VXRT) Presents at Oppenheimer 36th Annual Healthcare Life Sciences Conference - Slideshow
- Vaxart signals $700M COVID-19 vaccine milestone path as Sanofi partnership advances and 2026 data readouts approach
- Quant snapshot: Avino Silver & Gold, Harmony Gold lead strong buys as Angel Studios, Exagen lag
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。